Multi-attribute method (MAM) to assess analytical comparability of adalimumab biosimilars.

Millán-Martín, Silvia; Jakes, Craig; Carillo, Sara; Bones, Jonathan

Millán-Martín, Silvia; Jakes, Craig; Carillo, Sara; Bones, Jonathan.

Afiliação

Millán-Martín S; National Institute for Bioprocessing Research & Training, Fosters Avenue, Mount Merrion, Blackrock, A94 X099 Dublin, Ireland.
Jakes C; National Institute for Bioprocessing Research & Training, Fosters Avenue, Mount Merrion, Blackrock, A94 X099 Dublin, Ireland.
Carillo S; National Institute for Bioprocessing Research & Training, Fosters Avenue, Mount Merrion, Blackrock, A94 X099 Dublin, Ireland.
Bones J; National Institute for Bioprocessing Research & Training, Fosters Avenue, Mount Merrion, Blackrock, A94 X099 Dublin, Ireland; School of Chemical and Bioprocess Engineering, University College Dublin, Belfield, Dublin 4 D04 V1W8, Ireland. Electronic address: jonathan.bones@nibrt.ie.

J Pharm Biomed Anal ; 234: 115543, 2023 Sep 20.

Article em En | MEDLINE | ID: mdl-37385093

Assuntos

Medicamentos Biossimilares; Humanos; Adalimumab/química; Medicamentos Biossimilares/química; Anticorpos Monoclonais/química; Espectrometria de Massas; Glicosilação

Palavras-chave

Adalimumab; Biosimilars; Biotherapeutics; Critical quality attributes; HRAM MS; MAM

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Medicamentos Biossimilares Limite: Humans Idioma: En Revista: J Pharm Biomed Anal Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irlanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google